168 related articles for article (PubMed ID: 19660853)
1. The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts.
Ficarra V; Novara G; Martignoni G
Eur Urol; 2009 Nov; 56(5):782-4; discussion 784-5. PubMed ID: 19660853
[No Abstract] [Full Text] [Related]
2. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
Sun M; Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Pharand D; Latour M; Perrotte P; Patard JJ; Karakiewicz PI
Eur Urol; 2009 Nov; 56(5):775-81. PubMed ID: 19573980
[TBL] [Abstract][Full Text] [Related]
3. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
4. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
[TBL] [Abstract][Full Text] [Related]
5. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
6. Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma.
Hong SK; Jeong CW; Park JH; Kim HS; Kwak C; Choe G; Kim HH; Lee SE
BJU Int; 2011 Feb; 107(3):409-15. PubMed ID: 20804473
[TBL] [Abstract][Full Text] [Related]
7. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues.
Capitanio U; Montorsi F
Eur Urol; 2011 Jun; 59(6):929-30. PubMed ID: 21444146
[No Abstract] [Full Text] [Related]
8. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
[TBL] [Abstract][Full Text] [Related]
9. Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Blute ML
Eur Urol; 2010 Jan; 57(1):110-1. PubMed ID: 19062158
[No Abstract] [Full Text] [Related]
10. Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Giannarini G; Autorino R
Eur Urol; 2010 Jan; 57(1):109-10. PubMed ID: 19062156
[No Abstract] [Full Text] [Related]
11. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
12. Is simple enucleation a minimal partial nephrectomy responding to the EAU guidelines' recommendations?
Ficarra V; Galfano A; Cavalleri S
Eur Urol; 2009 Jun; 55(6):1315-8. PubMed ID: 18801609
[No Abstract] [Full Text] [Related]
13. Toward standardized anatomical classifications of small renal tumors.
Patard JJ
Eur Urol; 2009 Nov; 56(5):794-5. PubMed ID: 19740594
[No Abstract] [Full Text] [Related]
14. Editorial comment on: hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinoma and oncocytoma have excellent oncologic outcomes.
Becker F
Eur Urol; 2010 Apr; 57(4):666. PubMed ID: 19477584
[No Abstract] [Full Text] [Related]
15. Update on pathologic staging of renal cell carcinoma.
Gettman MT; Blute ML
Urology; 2002 Aug; 60(2):209-17. PubMed ID: 12137811
[No Abstract] [Full Text] [Related]
16. Editorial comment on: hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
Bex A
Eur Urol; 2010 Apr; 57(4):665. PubMed ID: 19477585
[No Abstract] [Full Text] [Related]
17. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
18. High-dose interleukin-2 in metastatic renal cell carcinoma.
Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
[No Abstract] [Full Text] [Related]
19. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
[TBL] [Abstract][Full Text] [Related]
20. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
